Latest News Senhwa Biosciences’ CX-5461 Teams Up with Global PD-1 Leaders to Enter the Immunotherapy Arena, Targeting Multi-Billion Dollar Global Market Sep 16 2025 Latest News Senhwa Biosciences CX-5461 Secures NCI Support to Advance into MYC-Driven Lymphoma, Driving Cross-Cancer and Global Licensing Value Sep 05 2025 Latest News Official Statement Sep 02 2025 Media Coverage Senhwa Biosciences Highlights Breakthroughs in Dual First-in-Class Drug Programs at Annual Shareholders' Meeting Today Jun 25 2025 Media Coverage Seven biotech companies keeping Taiwan dynamic in 2025 Mar 07 2025 Media Coverage Penn State College of Medicine, Beat Childhood Cancer Research Consortium and Four Diamonds launch clinical trial that aims to combat solid tumors Sep 30 2024 Publications Fibroblast growth receptor 1 is regulated by G-quadruplex in metastatic breast cancer Aug 09 2024 Publications CX-5461 Preferentially Induces Top2α-Dependent DNA Breaks at Ribosomal DNA Loci. Jul 08 2024 Publications Treatment of Ovarian Cancer Beyond PARP Inhibition: Current and Future Options Sep 22 2023